This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Innate Pharma, S.a.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Marcel Rozencweig: Innovator in Hematological Treatments
Introduction
Marcel Rozencweig is a notable inventor based in Marseilles, France. He has made significant contributions to the field of hematology through his innovative research and patents. His work focuses on developing methods for treating recurrent hematological malignancies.
Latest Patents
Marcel Rozencweig holds a patent for "Methods for treatment of recurrent hematological malignancies." This patent includes compositions comprising compounds that neutralize NK cell inhibitory receptors and outlines methods for using these compositions in the treatment of hematological malignancies. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Rozencweig is associated with Innate Pharma, S.A., a company dedicated to developing innovative immunotherapies for cancer treatment. His role at the company allows him to collaborate with other experts in the field, further enhancing his contributions to hematological research.
Collaborations
Some of his notable coworkers include Pascale Andre and Renaud Buffet. Their collaboration fosters a dynamic environment for research and innovation, leading to advancements in cancer treatment methodologies.
Conclusion
Marcel Rozencweig's work exemplifies the impact of innovation in the medical field, particularly in the treatment of hematological malignancies. His contributions through patents and collaboration with esteemed colleagues continue to pave the way for future advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile